Tango Therapeutics, Inc.

TNGX Net selling

CIK 0001819133 #1540 in the set updated 17 Sep 2026

Bought (120 mo)

$18.34M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$94.65M

$1.03M on a plan · $5.10M straight out of an exercise

Sold at will

$88.51M

66 of 81 sales

Net

−$76.31M

−$70.17M against sales at will

By person

21 insiders · 94 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Third Rock Ventures IV, L.P. entity

10% owner

—

$51.85M (24)

−$51.85M

13,386,574

7.94%

$299.42M

−30.9%

Boxer Capital Management, LLC entity

See remarks

—

$20.12M (4)

−$20.12M

10,301,284

6.11%

$230.41M

−30.8%

Boxer Capital, LLC entity

See remarks

$12.93M (10)

$2.24M (2)

+$10.69M

8,892,166

5.27%

$198.89M

+27.5%

EcoR1 Capital, LLC entity

10% owner

—

$8.44M (3)

−$8.44M

10,630,736

6.30%

$237.78M

−20.3%

Crystal Adam

President, R&D

—

$6.54M (21) scheduled

−$6.54M

115,743

0.0686%

$2.59M

+989.0%

BCTG Holdings, LLC entity

10% owner

$5.34M (1)

$30.00 (2)

+$5.33M

4,488,450

2.66%

$100.39M

+13.3%

MVA Investors, LLC entity

See remarks

—

$4.62M (8)

−$4.62M

592,317

0.3513%

$13.25M

−49.7%

Weber Barbara

Director, Executive Chair

—

$547.06K (6)

−$547.06K

1,629,254

0.9663%

$36.44M

+19.1%

Beckman Daniella

Chief Financial Officer

—

$198.71K (6)

−$198.71K

184,297

0.1093%

$4.12M

+188.6%

Rothenberg Mace

Director

$74.00K (2)

—

+$74.00K

41,500

0.0246%

$928.23K

—

Barry Douglas

General Counsel

—

$51.32K (4)

−$51.32K

66,014

0.0392%

$1.48M

—

Calhoun Lesley Ann

Director

—

$36.04K (1) scheduled

−$36.04K

16,500

0.0098%

$369.06K

—

Peters Malte

President & CEO

—

—

—

367,500

0.2180%

$8.22M

—

Huang Alan

Chief Scientific Officer

—

—

—

167,584

0.0994%

$3.75M

+23.3%

Gall Matthew

Chief Financial Officer

—

—

—

40,000

0.0237%

$894.68K

—

Ketchum John B

Director

—

—

—

24,937

0.0148%

$557.77K

—

Lee Sung

Director

—

—

—

22,870

0.0136%

$511.53K

—

Borisy Alexis

Director

—

—

—

17,500

0.0104%

$391.42K

—

Azelby Robert

Director

—

—

—

5,740

0.0034%

$128.39K

—

Davis Aaron I.

See remarks.

—

—

—

5,000

0.0030%

$111.84K

—

Huber Reid M

Director

—

—

—

5,000

0.0030%

$111.84K

—

Individual transactions

3

Insider

Date

Role

Action

Shares

Price

Amount

Crystal Adam

5 Mar 2026

President, R&D

Sold on a plan

20,251

$15.00

$303.77K

Crystal Adam

25 Feb 2026

President, R&D

Sold on a plan

54,345

$12.77

$694.21K

Calhoun Lesley Ann

5 Jun 2024

Director

Sold on a plan

5,000

$7.21

$36.04K

Show all 94 transactions →

What was left out

Form 4 filings counted 111

Amendments (4/A) skipped 2

Filings about a different issuer 1

Unreadable filings 0

Joint filings 29

Sales on a Rule 10b5-1 plan 3

Sales straight out of an exercise 12

Sales at will 66

Transactions with no price 0

Shares from compensation/vesting 1,540,962

Sales filed before the plan box existed 2

History held since 10 Sep 2020